Nephrocare Health IPO Subscription Status
Nephrocare Health IPO received bids for 18,68,94,880 shares against 1,33,87,854 offered, an overall subscription of 13.96x at the close of bidding (12 Dec 2025). QIBs lead at 27.47x.
Last updated · day 3 figures
- Retail
- 2.31x
- NII
- 24.27x
- QIB
- 27.47x
- Total
- 13.96x
Where the demand is
Nephrocare Health IPO subscription by category
| Category | Shares offered | Shares bid | Amount bid | Subscription |
|---|---|---|---|---|
| QIB | 36,78,793 | 10,10,69,088 | ₹4,649.18 Cr | 27.47x |
| NII | 28,86,270 | 7,00,52,352 | ₹3,222.41 Cr | 24.27x |
| bNII above ₹10 lakh | 19,24,180 | 5,73,66,080 | ₹2,638.84 Cr | 29.81x |
| sNII ₹2–10 lakh | 9,62,090 | 1,26,86,272 | ₹583.57 Cr | 13.19x |
| Retail | 67,34,630 | 1,55,38,304 | ₹714.76 Cr | 2.31x |
| Employees | 88,161 | 2,35,136 | ₹10.82 Cr | 2.67x |
| Total | 1,33,87,854 | 18,68,94,880 | ₹8,597.16 Cr | 13.96x |
* Shares Offered and Total Amount are calculated based on the upper price of the issue price range. * The portion of anchor investors (or market makers) is not included in the total number of shares offered.
Nephrocare Health IPO subscription day-wise
| Category | Day 3 |
|---|---|
| QIB | 27.47x |
| NII | 24.27x |
| bNII | 29.81x |
| sNII | 13.19x |
| Retail | 2.31x |
| Employees | 2.67x |
| Total | 13.96x |
| Total added | 13.96x |
Cumulative figures at the end of each day. Read across a row to see how demand built up. Shading deepens as subscription rises above 1x; "Total added" is how much overall subscription grew that day.
Nephrocare Health IPO reservation
| Category | Shares | Share of issue |
|---|---|---|
| Qualified Institutional Buyers | 36,78,793 | 27.48% |
| Non-Institutional Investors | 28,86,270 | 21.56% |
| bNII · above ₹10 lakh | 19,24,180 | 67% of NII |
| sNII · ₹2–10 lakh | 9,62,090 | 33% of NII |
| Retail Individual Investors | 67,34,630 | 50.30% |
| Employee reservation | 88,161 | 0.66% |
| Public issue | 1,33,87,854 | 100% |
Allotment Chances Note
These are estimates from the latest application and subscription figures. Actual chances are usually somewhat better, because:
- Not every bid is at the cut-off price. Bids below the final issue price are rejected before the lottery, so fewer applications compete.
- Multiple-lot applications count once. In an oversubscribed retail or sNII portion, each application gets at most one minimum lot in the draw, however many lots it bid for.
- Invalid applications drop out. Unapproved UPI mandates, PAN mismatches and duplicate applications are removed before allotment.
Applying for more lots in the retail category does not improve your odds; applying from separate family accounts does.
Nephrocare Health IPO subscription: FAQs
- What is the overall subscription of Nephrocare Health IPO?
- Nephrocare Health IPO is subscribed 13.96x overall as of day 3 (12 December 2025), with bids for 18,68,94,880 shares against 1,33,87,854 offered.
- What is the retail subscription of Nephrocare Health IPO?
- The retail portion is subscribed 2.31x as of day 3 (12 December 2025).
- What is the QIB and NII subscription of Nephrocare Health IPO?
- QIBs have subscribed 27.47x of their portion, and NIIs 24.27x (bNII 29.81x, sNII 13.19x) as of day 3 (12 December 2025).
- How can I check Nephrocare Health IPO subscription status live?
- This page shows category-wise and day-wise figures and is updated during bidding hours. The same data is published on the BSE and NSE websites under the issue name.
- How do I apply for Nephrocare Health IPO?
- Apply online through your broker or bank using UPI or ASBA. Choose the IPO, enter the number of lots and bid price (retail investors can bid at the cut-off price), and approve the UPI mandate before the issue closes on 12 December 2025.
Subscription figures are compiled from BSE and NSE bid data and can be revised by the exchanges after the issue closes. For information only; not investment advice.